Choice of vascular access among incident hemodialysis patients: A decision and cost-utility analysis

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 12, 2010, Pages 2289-2296

  Xue, Hui ^a   Lacson Jr , Eduardo ^b   Wang, Weiling ^b   Curhan, Gary C ^a   Brunelli, Steven M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS FISTULA; ARTICLE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE COST; HEMODIALYSIS PATIENT; HIDDEN MARKOV MODEL; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; QUALITY ADJUSTED LIFE YEAR; TREATMENT PLANNING; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; COSTS AND COST ANALYSIS; HUMANS; MARKOV CHAINS; PROBABILITY; RENAL DIALYSIS;

EID: 78650326842     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03210410     Document Type: Article

References (28)

1. National Kidney Foundation Kidney Disease Outcomes Quality Initiative Guidelines: Clinical Practice Guidelines and Clinical Practice Recommendations: Bethesda, MD, National Kidney Foundation, 2006
2. Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall T, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG on vascular access. Nephrol Dial Transplant 22[Suppl 2]: ii88-ii117, 2007
3. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident U.S. hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2: 89-99, 2007
4. Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 study. Kidney Int 68: 311-318, 2005 (Pubitemid 43181390)
5. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 16: 1449-1455, 2005
6. Gulati S, Sahu KM, Avula S, Sharma RK, Ayyagiri A, Pandey CM: Role of vascular access as a risk factor for infections in hemodialysis. Ren Fail 25: 967-973, 2003 (Pubitemid 37487087)
7. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60: 1443-1451, 2001
8. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 55: 1081-1090, 1999 (Pubitemid 29100722)
9. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: A randomized controlled trial. JAMA 299: 2164-2171, 2008 (Pubitemid 351679707)
10. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D: Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 17: 3204-3212, 2006 (Pubitemid 44707782)
11. Biuckians A, Scott EC, Meier GH, Panneton JM, Glickman MH: The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. J Vasc Surg 47: 415-421, 2008 (Pubitemid 351172675)
12. Feldman HI, Joffe M, Rosas SE, Burns JE, Knauss J, Brayman K: Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis 42: 1000-1012, 2003 (Pubitemid 37322917)
13. Chemla ES, Morsy MA: Is basilic vein transposition a real alternative to an arteriovenous bypass graft? A prospective study. Semin Dial 21: 352-356, 2008
14. Foley RN, Chen SC, Collins AJ: Hemodialysis access at initiation in the United States, 2005 to 2007: Still "catheter first". Hemodial Int 13: 533-542, 2009
15. Wasse H, Kutner N, Zhang R, Huang Y: Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clin J Am Soc Nephrol 2: 708-714, 2007
16. Brothers TE, Cox MH, Robison JG, Elliott BM, Nietert P: Prospective decision analysis modeling indicates that clinical decisions in vascular surgery often fail to maximize patient expected utility. J Surg Res 120: 278-287, 2004
17. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, 2009
18. Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA: Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: A probabilistic analysis. J Antimicrob Chemother 63: 816-825, 2009
19. U.S. Department of Health and Human Services. Centers for Medicare and Medicaid Services. Available at: http://www.medicarenhic.com/ne-prov/fees/ January%202010%20ASP%20Price%20File.pdf. Accessed February 16, 2010
20. Chand DH, Teo BW, Fatica RA, Brier M: Influence of vascular access type on outcome measures in patients on maintenance hemodialysis. Nephrol Clin Pract 108: c91-c98, 2008 (Pubitemid 351346931)
21. Berman SJ, Johnson EW, Nakatsu C, Alkan M, Chen R, LeDuc J: Burden of infection in patients with end-stage renal disease requiring long-term dialysis. Clin Infect Dis 39: 1747-1753, 2004
22. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH: Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database Crit Care Med 34: 2588-2595, 2006
23. Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey RG, Schulman KA, Fowler VG: Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26: 175-183, 2005
24. Xue JL, Dahl D, Ebben JP, Collins AJ: The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 42: 1013-1019, 2003
25. Huber TS, Carter JW, Carter RL, Seeger JM: Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: A systematic review. J Vasc Surg 38: 1005-1011, 2003
26. Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, Blankestijn PJ; CIMINO study group: Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 3: 714-719, 2008
27. Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR Jr, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI: Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 360: 2191-2201, 2009
28. Rajan DK, Bunston S, Misra S, Pinto R, Lok CE: Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty - Are there clinical predictors of patency? Radiology 232: 508-515, 2004